The Native Antigen Company Introduces Novel Coronavirus Antigens
Drug Discovery Today
FEBRUARY 12, 2020
Newly developed recombinant antigens derived specifically from 2019-nCoV for use in infectious disease research, and assay and vaccine development
Let's personalize your content